Lisa Moore
Corporate Officer/Principal bei RAPT THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Lisa Moore
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lisa Moore
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Human Resources Officer | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Founder Private Equity Investor | |
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| San Jose State University | College/University | Graduate Degree Undergraduate Degree | |
| XENOPORT, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
| CERUS CORPORATION | Medical Specialties | Public Communications Contact Corporate Officer/Principal | |
| San Francisco State University | College/University | Undergraduate Degree Undergraduate Degree | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Human Resources Officer | |
| Weill Cornell Medicine | College/University | Corporate Officer/Principal | |
Oncovalent Therapeutics, Inc.
 Oncovalent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncovalent Therapeutics, Inc. develops immuno oncology drugs and therapeutics. The company is based in Thousand Oaks, CA. Pete Feldman has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Amdahl Corp.
 Amdahl Corp. Computer Processing HardwareElectronic Technology Part of Fujitsu Ltd., Amdahl Corp. is a company that operates an electronic computer manufacturing company. The company is based in Sunnyvale, CA. The company was founded by Raymond A. Williams. Amdahl was acquired by Fujitsu Ltd. on September 19, 1997 for $834.03 million. | Computer Processing Hardware | Human Resources Officer | |
| INTERSECT ENT, INC. | Medical/Nursing Services | Human Resources Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| University of Michigan | College/University | Undergraduate Degree | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree | |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Pharmaceuticals: Major | Director/Board Member | |
| ARAVIVE, INC. | Biotechnology | Chief Executive Officer | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Investment Managers | Consultant / Advisor | |
| Neurogen Technologies, Inc. | Corporate Officer/Principal | ||
| Stanford University | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 3 |
| Indien | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 12 |
| Finance | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 114 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 48 |
| Undergraduate Degree | 25 |
| Director of Finance/CFO | 21 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Beth Seidenberg | 39 |
| Mary Gray | 27 |
| David Goeddel | 27 |
| Peter Svennilson | 25 |
| Eric J. Hall | 18 |
| Rekha Hemrajani | 17 |
| William Rieflin | 16 |
| Sylvia R. Wheeler | 14 |
| Wendye Robbins | 12 |
| Lori Lyons-Williams | 11 |
| Phyllis Loud Gray | 9 |
| Michael Giordano | 9 |
| David J. Wustrow | 9 |
| Brian Wong | 9 |
| Gwen R. Carscadden | 8 |
- Börse
- Insiders
- Lisa Moore
- Unternehmensverbindungen
